GSK gets cancer immunotherapies from Ludwig Institute
The Ludwig Institute for Cancer Research has licensed GlaxoSmithKline rights to a group of antigens expressed in various cancers including melanoma and non-small cell lung, breast, head and neck, bladder, and liver cancers.
- Large Molecule
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.